These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31107629)

  • 1. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.
    Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP
    J Oncol Pract; 2019 Jul; 15(7):e616-e627. PubMed ID: 31107629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer.
    Banegas MP; Hassett MJ; Keast EM; Carroll NM; O'Keeffe-Rosetti M; Fishman PA; Uno H; Hornbrook MC; Ritzwoller DP
    Value Health; 2022 Jan; 25(1):69-76. PubMed ID: 35031101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis.
    Ritzwoller DP; Fishman PA; Banegas MP; Carroll NM; O'Keeffe-Rosetti M; Cronin AM; Uno H; Hornbrook MC; Hassett MJ
    Health Serv Res; 2018 Dec; 53(6):5106-5128. PubMed ID: 30043542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
    Chen CT; Li L; Brooks G; Hassett M; Schrag D
    Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2(-) metastatic breast cancer.
    Engel-Nitz NM; Hao Y; Becker LK; Gerdes R
    J Comp Eff Res; 2015 Aug; 4(4):303-14. PubMed ID: 26274792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variation in spending and survival for older adults with advanced cancer.
    Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
    J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-cost imaging in elderly patients with stage IV cancer.
    Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
    J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
    Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
    Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
    Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
    J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
    Stokes ME; Thompson D; Montoya EL; Weinstein MC; Winer EP; Earle CC
    Value Health; 2008; 11(2):213-20. PubMed ID: 18380633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies.
    Youn B; Wilson IB; Mor V; Trikalinos NA; Dahabreh IJ
    Health Serv Res; 2021 Jun; 56(3):486-496. PubMed ID: 33682120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
    Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
    Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.